Stocks · Korea 246960 KOSDAQ

SCL Science

2,850원 +0.35% Market cap 969억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR3.96x
EPS0 KRW
BPS719 KRW
ROE-15.53%
DPS0 KRW

Returns and 52-week range

1W+4.01%
1M+26.39%
3M+67.75%
6M+29.55%
1Y+7.55%
YTD+23.11%
52W high3,250원
52W low1,389원
From 52W high-12.31%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20224억-46억-60억-1,245.4%
202313억-40억-50억-303.9%
202447억-37억-37억-77.3%
2025220억-34억-41억-15.4%
Quarterly
2024 4Q16억-14억-13억-85.5%
2025 1Q23억-13억-16억-59.5%
2025 2Q45억-14억2억-30.5%
2025 3Q70억2억-1억2.4%
2025 4Q83억-8억-26억-10.2%
2026 1Q77억-6억-10억-8.4%

Company

CEO이경률, 백세연 (각자대표)
Founded2010-04-19
Fiscal year end12
Address: 서울특별시 영등포구 선유로13길 25 에이스하이테크시티 2차 1209호

Peers in the same sector

CompanyMarket capP/EP/B1M
한국파마985억—1.43+17.27%
위더스제약942억18.990.96+2.28%
아스타994억—9.98+0.00%
국제약품937억15.820.96+30.87%
녹십자엠에스1,006억24.852.06+33.17%
삼아제약891억6.600.37+0.29%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.